Rani Therapeutics Holdings Inc (RANI)

Rani Therapeutics Holdings Inc (RANI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $103M; returns 1 day +3.1%, 1 week -5.4%, 1 year -71.0%.

Rani Therapeutics is a clinical-stage biotherapeutics company specializing in the oral delivery of biologics, a class of drugs traditionally requiring subcutaneous injection or intravenous infusion due to their size and susceptibility to digestive enzymes.

Groups RANI belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Biologics
• Life Sciences
• Pharmaceuticals
• Robotics
• Biopharmaceutical
• Healthcare Innovation
• GLP-1 Agonists
• Medical Devices

RANI financial model: income statement, cash flow and balance sheet